OUTCOME OF PATIENTS ADMITTED WITH ACUTE LOWER EXTREMITY ISCHEMIA

NCT ID: NCT05255640

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

176 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-04

Study Completion Date

2023-11-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute ischemia of the lower limb (AMI) is a life-threatening emergency that threatens the functional prognosis of the limb. Depending on the clinical presentation and the anatomy of the patient, several therapeutic approaches can be considered: open surgery, endovascular surgery, hybrid surgery or amputation if revascularization is not feasible. The data in the current literature do not allow to clearly establish which therapeutic approach is the most adapted to the patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Ischemia of Lower Limb

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with ischemia of the lower limbs

operation of ischemia of the lower limbs

Intervention Type PROCEDURE

The intervention technique is left to the judgment of the investigator to treat the ischemia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

operation of ischemia of the lower limbs

The intervention technique is left to the judgment of the investigator to treat the ischemia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than 18 years, regardless of gender.
* Diagnosis of AMI defined according to the Rutherford classification (2). AMI may involve one or both lower limbs.
* Be able to understand and give free and informed consent (non-opposition) to participate in the study
* To be affiliated to the social security system
* Not to object to participating in the study (collection of non-objection)

Exclusion Criteria

* Voluntary discharge of the patient: opposition to the use of the data (withdrawal of the non-objection)
* Termination of the study by decision of the sponsor or investigator.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nice

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Besançon university hospital

Besançon, , France

Site Status

Bordeaux University Hospital

Bordeaux, , France

Site Status

Brest University Hospital

Brest, , France

Site Status

Dijon University Hospital

Dijon, , France

Site Status

Lyon University Hospital

Lyon, , France

Site Status

Nancu University Hospital

Nancy, , France

Site Status

Nantes University Hospital

Nantes, , France

Site Status

Nice University Hospital

Nice, , France

Site Status

APHP - Hôpital Mondor

Paris, , France

Site Status

APHP- Ambroise Paré

Paris, , France

Site Status

APHP- Hôpital Bichat

Paris, , France

Site Status

APHP- Hôpital Européen Georges Pompidou

Paris, , France

Site Status

Reims University Hospital

Reims, , France

Site Status

Strasbourg University Hospital

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-PP-27

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The CLI-AMP Registry
NCT04427124 UNKNOWN